Pnc Financial Services Group, Inc. Ocular Therapeutix, Inc Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$4.2 - $8.69 $67 - $139	-16 Reduced 13.11%	106 $0
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $427 - $1,213	111 Added 1009.09%	122 $1,000
Q4 2023 Feb 09, 2024	BUY	$2.08 - $4.52 $22 - $49	11 New	11 $0
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $4,830 - $7,350	-1,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.16 - $12.07 $6,160 - $12,070	1,000 New	1,000 $6,000
Q3 2018 Nov 09, 2018	SELL	$5.42 - $6.99 $8,130 - $10,485	-1,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$5.99 - $8.17 $8,985 - $12,255	1,500 New	1,500 $0

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.